Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA

被引:137
作者
Terada, K
Nakako, T
Yang, XL
Iida, M
Aiba, N
Minamiya, Y
Nakai, M
Sakaki, T
Miura, N
Sugiyama, T
机构
[1] Akita Univ, Sch Med, Dept Biochem, Akita 010, Japan
[2] Akita Univ, Sch Med, Dept Surg, Akita 010, Japan
[3] Sumitomo Pharmaceut Co Ltd, Res Ctr, Discovery Res Labs 3, Osaka 554, Japan
关键词
D O I
10.1074/jbc.273.3.1815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wilson's disease, an autosomal recessive disorder, is characterized by the excessive accumulation of copper in the liver. WND (ATP7B) gene, which encodes a putative copper transporting P-type ATPase, is defective in the patients. To investigate the in vivo function of WND protein as well as its intracellular localization, WND cDNA was introduced to the Long-Evans Cinnamon rat, known as a rodent model for Wilson's disease, by recombinant adenovirus-mediated gene delivery. An immunofluorescent study and a subcellular fractionation study revealed the transgene expression in liver and its localization to the Golgi apparatus. Moreover, since the synthesis of holoceruloplasmin is disturbed in the Long-Evans Cinnamon rat, the plasma level of holoceruloplasmin, oxidase-active and copper-bound form, was examined to evaluate the function of WND protein with respect to the copper transport. Consequently, the appearance of holoceruloplasmin in plasma was confirmed by Western blot analysis and plasma measurements for the oxidase activity and the copper content. These findings indicate that introduced WND protein may function in the copper transport coupled with the synthesis of ceruloplasmin and that the Golgi apparatus is the likely site for WND protein to manifest its function.
引用
收藏
页码:1815 / 1820
页数:6
相关论文
共 46 条
[1]  
BUIL PC, 1993, NAT GENET, V5, P327
[2]   Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy [J].
Chen, GX ;
Koyama, K ;
Yuan, X ;
Lee, Y ;
Zhou, YT ;
ODoherty, R ;
Newgard, CB ;
Unger, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14795-14799
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   ADMINISTRATION OF AN ADENOVIRUS CONTAINING THE HUMAN CFTR CDNA TO THE RESPIRATORY-TRACT OF INDIVIDUALS WITH CYSTIC-FIBROSIS [J].
CRYSTAL, RG ;
MCELVANEY, NG ;
ROSENFELD, MA ;
CHU, CS ;
MASTRANGELI, A ;
HAY, JG ;
BRODY, SL ;
JAFFE, HA ;
EISSA, NT ;
DANEL, C .
NATURE GENETICS, 1994, 8 (01) :42-51
[5]   ABLATION OF E2A IN RECOMBINANT ADENOVIRUSES IMPROVES TRANSGENE PERSISTENCE AND DECREASES INFLAMMATORY RESPONSE IN MOUSE-LIVER [J].
ENGELHARDT, JF ;
YE, XH ;
DORANZ, B ;
WILSON, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6196-6200
[6]  
FRIEDEN E, 1981, MET IONS BIOL SYST, V13, P117
[7]   Biochemical characterization of the Wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae [J].
Hung, IH ;
Suzuki, M ;
Yamaguchi, Y ;
Yuan, DS ;
Klausner, RD ;
Gitlin, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21461-21466
[8]   EFFICIENT GENE ACTIVATION IN MAMMALIAN-CELLS BY USING RECOMBINANT ADENOVIRUS EXPRESSING SITE-SPECIFIC CRE RECOMBINASE [J].
KANEGAE, Y ;
LEE, G ;
SATO, Y ;
TANAKA, M ;
NAKAI, M ;
SAKAKI, T ;
SUGANO, S ;
SAITO, I .
NUCLEIC ACIDS RESEARCH, 1995, 23 (19) :3816-3821
[9]   A SIMPLE AND EFFICIENT METHOD FOR PURIFICATION OF INFECTIOUS RECOMBINANT ADENOVIRUS [J].
KANEGAE, Y ;
MAKIMURA, M ;
SAITO, I .
JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1994, 47 (03) :157-166
[10]   GENE-THERAPY FOR METABOLIC DISORDERS [J].
KAY, MA ;
WOO, SLC .
TRENDS IN GENETICS, 1994, 10 (07) :253-257